This week’s market sell-off interrupted the S&P 500’s gain streak, but it also offers investors an opportunity to gain exposure ahead of a potential rebound. Friday’s release of the Federal Reserve’s favorite inflation measure came as expected, but the three major indexes are on pace to fall this week. Both the S&P 500 and Nasdaq Composite are on pace to break five-week gain streaks, while the Dow Jones Industrial Average is on track to lose for a second straight week. Salesforce.com, a component of the Dow Jones Industrial Average, fell about 19% this week, making it the most oversold stock on the market. Investors sold the company’s shares after the company released weaker-than-expected earnings and weak guidance on Wednesday. With this in mind, CNBC Pro screened Wall Street’s most overbought and oversold stocks, as measured by the 14-day Relative Strength Index (RSI). Stocks with a 14-day RSI below 30 are considered oversold, suggesting that it may be time for a recovery. Meanwhile, a stock with a 14-day RSI above 70 is overbought, signaling it may soon fall back. The weekly data below is as of 9:38 a.m. ET on Friday. Salesforce’s 14-day RSI is at 16.4. Year-to-date, the stock is down 13%. The stock fell about 20% on Thursday alone. Salesforce’s quarterly earnings disappointed investors, but many Wall Street analysts remain optimistic about the stock and its prospects for artificial intelligence, maintaining a consensus buy rating. Goldman Sachs described the company as an “undervalued Gen-AI winner,” while Morgan Stanley also highlighted the future benefits of AI. The stock is expected to soar more than 37% from here, according to analysts surveyed by LSEG. Biopharmaceutical company Bristol-Myers Squibb was the second most oversold stock this week. The stock has fallen more than 2% so far this week, with a near 20% decline in 2024. Analysts rate the stock a Hold. The company is pursuing a $1.5 billion cost-cutting plan by 2025, which it plans to implement through layoffs, consolidation of roles, discontinuing some drug programs, and other cost-cutting measures. According to Bristol-Myers Squibb’s average price target, the stock could rise by more than 29%. Here are some of the most overbought stocks this week. Technology company HP surged 17.1% this week, making it the most overbought stock with an RSI near 90. The company announced Wednesday that its second-quarter profit and sales beat expectations. Half of the analysts covering HP rate the stock as a strong buy or buy, but the rally may not be sustainable. Analysts’ consensus price targets suggest the stock could fall by more than 5% from current levels. The stock fell by more than 6% on Friday, but is up about 20% year to date. HPQ YTD Mountain HP Stock 2024 Ralph Lauren is another overbought stock that has risen almost 7% this week. The company’s RSI is at 76.9, and analysts expect it to rise by more than 3% from here. The apparel company’s fiscal fourth-quarter profit beat analysts’ expectations. The company also announced a 10% dividend increase. Its shares rose about 14% in May and are on track to rise nearly 30% in 2024.
Subscribe to Updates
Subscribe to our newsletter and stay updated with the latest news and exclusive offers.
Salesforce is the most oversold stock during market losing week
Related Posts
Add A Comment
Services
Subscribe to Updates
Subscribe to our newsletter and stay updated with the latest news and exclusive offers.
© 2026 Business Investopedia. All Rights Reserved.
